GD
39
-2
HCP
52
9
LB
9
-3
GLW
41
-4
AN
55
-2
LRCX
65
6
CTSH
56
4
TSN
32
-3
EXC
51
-2
NI
67
2
CCL
72
2
CINF
31
2
EL
37
-3
NEM
50
2
AA
29
-5
MRK
25
-5
VRSK
63
-3
TDC
86
2
PHM
55
-3
SYF
86
3
GD
39
-2
HCP
52
9
LB
9
-3
GLW
41
-4
AN
55
-2
LRCX
65
6
CTSH
56
4
TSN
32
-3
EXC
51
-2
NI
67
2
CCL
72
2
CINF
31
2
EL
37
-3
NEM
50
2
AA
29
-5
MRK
25
-5
VRSK
63
-3
TDC
86
2
PHM
55
-3
SYF
86
3
Financhill
Back

Orchestra BioMed Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
49

OBIO
Orchestra BioMed Holdings

Last Price:
5.33
Seasonality Move:
4.23%
Sell
16

NBY
NovaBay Pharmaceuticals

Last Price:
0.56
Seasonality Move:
-8.54%
Sell
49
Orchestra BioMed Holdings (OBIO) is a Sell

Is Orchestra BioMed Holdings a Buy, Sell or Hold?

  • The current Orchestra BioMed Holdings [OBIO] share price is $5.35. The Score for OBIO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • OBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OBIO Stock Price Chart

What is Orchestra BioMed Holdings's stock price today?

  • The Orchestra BioMed Holdings share price today is $5.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OBIO is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

OBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 46.84 Sell
Chaikin Money Flow: -24779 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.31 - 6.03) Sell
Bollinger Bands (100): (5.06 - 6.54) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 32.51 Sell
Chaikin Money Flow: -111892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.35 - 0.97) Sell

OBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.39 Sell
20-day SMA: 5.57 Sell
50-day SMA: 5.54 Sell
200-day SMA: 5.96 Sell
8-day EMA: 5.42 Sell
20-day EMA: 5.52 Sell
50-day EMA: 5.61 Sell
200-day EMA: 6.19 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.58 Sell
20-day SMA: 0.64 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2.04 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.62 Sell
50-day EMA: 0.68 Sell
200-day EMA: 5 Sell

Orchestra BioMed Holdings Earnings Growth & OBIO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.29 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Orchestra BioMed Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):